Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 16,564 $ 39,013
Accounts receivable, net 6,732 6,263
Inventories, net 28,104 27,083
Contract assets 4,120 2,039
Prepaid expenses and other current assets 9,650 5,722
Total current assets 65,170 80,120
Property and equipment, net 16,387 13,094
Equipment subject to operating lease, net 1,054 1,629
Other assets 9,793 10,505
Total assets 92,404 105,348
Current liabilities:    
Accounts payable 9,089 10,301
Accrued expenses and other current liabilities 6,655 7,915
Debt – current portion 3,135 6,305
Contract liabilities 7,739 9,281
Total current liabilities 26,618 33,802
Long-term debt – less current portion 6,037 24,710
Contingent earnout liabilities (Note 10) 1 1
Warrant liabilities (Note 10) 109 109
Other noncurrent liabilities 8,099 8,570
Total liabilities 40,864 67,192
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00001 par value - 500,000,000 shares authorized at March 31, 2026 and December 31, 2025, respectively, 26,216,822 and 24,607,630 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 5 5
Additional paid-in capital 556,676 536,294
Accumulated deficit (505,141) (498,143)
Total stockholders’ equity 51,540 38,156
Total liabilities and stockholders’ equity $ 92,404 $ 105,348